Author: Sallo Ferenc B. Leung Irene Mathenge Wanjiku Kyari Fatima Kuper Hannah Gilbert Clare E. Bird Alan C. Peto Tunde
Publisher: Informa Healthcare
ISSN: 0928-6586
Source: Ophthalmic Epidemiology, Vol.19, Iss.4, 2012-08, pp. : 185-189
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Unusual Presentations of Type 2 Idiopathic Macular Telangiectasia
Ophthalmologica, Vol. 230, Iss. 3, 2013-08 ,pp. :
Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia
Ophthalmic Research, Vol. 49, Iss. 4, 2013-01 ,pp. :
Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
Case Reports in Ophthalmology, Vol. 5, Iss. 3, 2014-11 ,pp. :
How Prevalent is Macular Telangiectasia Type 2?
Ophthalmic Epidemiology, Vol. 19, Iss. 4, 2012-08 ,pp. :